Abeona Therapeutics (NASDAQ: ABEO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-27 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.100 | -0.0100 | ||||
REV | 346.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Other companies in Abeona Therapeutics’s space includes: Biocept (NASDAQ:BIOC), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by SVB Leerink on Tuesday, November 30, 2021. The analyst firm set a price target for 1.00 expecting ABEO to rise to within 12 months (a possible 489.97% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $0.1695 last updated May 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for Abeona Therapeutics.
Abeona Therapeutics’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for Abeona Therapeutics.
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.